208000003269 Mitochondrial Disease Diseases 0.000 title claims abstract description 103.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US68682605P priority Critical Priority to US70181505P priority Priority to US77602806P priority Application filed by Bioelectron Technology Corp filed Critical Bioelectron Technology Corp Priority to PCT/US2006/021295 priority patent/WO2006130775A2/en Publication of EP1888059A2 publication Critical patent/EP1888059A2/en Application granted granted Critical Publication of EP1888059B1 publication Critical patent/EP1888059B1/en Priority claimed from CY20151100256T external-priority patent/CY1116346T1/en Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links Original Assignee Bioelectron Technology Corp Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) University of Virginia HECHT Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Granted Application number EP06784530A Other languages German ( de) Google Patents Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomakers Google Patents EP1888059A2 - Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomakers

EP1888059A2 - Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomakers

Sayibregh ebs program